Application progress of the symptom science model in symptom management of patients with type 2 diabetes mellitus

doi:10.3761/j.issn.0254-1769.2026.09.019

Abstract

Abstract:

The Symptom Science Model serves as a systematic framework for symptom management，enabling the development of precise nursing interventions based on the biological mechanisms underlying symptoms，providing personalized nursing support for symptom management of patients with type 2 diabetes. This article reviews the concept，core elements，and application of the Symptom Science Model in symptom management for patients with type 2 diabetes，and proposes nursing-related recommendations to provide a reference for the scientific management of symptoms in these patients.

Key words: Symptom Science Model, Type 2 Diabetes Mellitus, Symptom Management, Precision Nursing, Review

摘要：

症状科学模型作为系统化症状管理框架，可基于症状的生物学机制制订精准的护理干预方案，为2型糖尿病患者症状管理提供个性化护理支持。该文对症状科学模型的概念及发展历程、核心要素、在2型糖尿病患者症状管理中的应用进行综述，并提出与护理相关的建议，以期为2型糖尿病患者症状的科学管理提供参考。

关键词: 症状科学模型, 2型糖尿病, 症状管理, 精准护理, 综述

ZHANG Shiyang, LIU Qiaoyu, LIN Xiaoling, AI Xingxing, CHEN Ciduan, HUANG Jiewei. Application progress of the symptom science model in symptom management of patients with type 2 diabetes mellitus[J]. Chinese Journal of Nursing, 2026, 61(9): 1284-1290.

张诗阳, 刘荞瑀, 林小灵, 艾星星, 陈慈端, 黄洁微. 症状科学模型在2型糖尿病患者症状管理中的应用进展[J]. 中华护理杂志, 2026, 61(9): 1284-1290.

References 41

[1]	Genitsaridi I, Salpea P, Salim A, et al. 11th edition of the IDF Diabetes Atlas:global,regional,and national diabetes prevale-nce estimates for 2024 and projections for 2050[J]. Lancet Dia-betes Endocrinol, 2026, 14(2):149-156.
[2]	American Diabetes Association Professional Practice Committee 2. diagnosis and classification of diabetes:standards of care in diabetes-2024[J]. Diabetes Care, 2024, 47(Suppl 1):S20-S42.
[3]	GBD 2021 Diabetes Collaborators. Global,regional,and national burden of diabetes from 1990 to 2021,with projections of prevalence to 2050:a systematic analysis for the Global Bur-den of Disease Study 2021[J]. Lancet, 2023, 402(10397):203-234.
[4]	García AA, Bose E, Zuñiga JA, et al. Mexican Americans’ dia-betes symptom prevalence,burden,and clusters[J]. Appl Nurs Res, 2019, 46:37-42.
[5]	Cashion AK, Grady PA. The National Institutes of Health/Natio-nal Institutes of Nursing Research intramural research program and the development of the National Institutes of Health Sym-ptom Science Model[J]. Nurs Outlook, 2015, 63(4):484-487.
[6]	杨珍娇, 崔妙玲, 张小芳, 等. 慢性阻塞性肺疾病病人症状群及其与炎症因子水平的相关性[J]. 护理研究, 2021, 35(7):1134-1139.
	Yang ZJ, Cui ML, Zhang XF, et al. Symptom clusters of patients with chronic obstructive pulmonary disease and its correlation with the levels of inflammatory biomarkers[J]. Chin Nurs Res, 2021, 35(7):1134-1139.
[7]	梁轶岚, 姜伟, 何小爽, 等. 症状科学模型在慢性肾脏疾病患者中的研究进展及护理启示[J]. 中华护理杂志, 2025, 60(5):624-629.
	Liang YL, Jiang W, He XS, et al. Research progress of symp-tom science model in chronic kidney disease[J]. Chin J Nurs, 2025, 60(5):624-629.
[8]	Hickey KT, Bakken S, Byrne MW, et al. Precision health:ad-vancing symptom and self-management science[J]. Nurs Out-look, 2019, 67(4):462-475.
[9]	Kurnat-Thoma EL, Graves LY, Billones RR. A concept develop-ment for the symptom science model 2.0[J]. Nurs Res, 2022, 71(6):E48-E60.
[10]	Zhang JL, Zhang ZY, Zhang KQ, et al. Early detection of type 2 diabetes risk:limitations of current diagnostic criteria[J]. Front Endocrinol, 2023, 14:1260623.
[11]	Li HJ, Ji MH, Scott P, et al. The effect of symptom clusters on quality of life among patients with type 2 diabetes[J]. Diabetes Educ, 2019, 45(3):287-294.
[12]	张慧慧. 2型糖尿病患者症状群及相关变量的结构关系模型构建[D]. 广州: 广州中医药大学, 2022.
	Zhang HH. Construction of a structural relationship model of symptom clusters and related variables in patients with type 2 diabetes mellitus[D]. Guangzhou: Guangzhou University of Chinese Medicine, 2022.
[13]	Liu YQ, Li SB, Li YM, et al. Exploring core and bridge symp-toms among people with type 2 diabetes mellitus in China:a network analysis[J]. J Clin Nurs, 2025.
[14]	谭婷婷, 王偲景, 杨涵, 等. 2型糖尿病患者症状网络及影响因素研究[J]. 中华现代护理杂志, 2025(15):2046-2052.
	Tan TT, Wang CJ, Yang H, et al. Study on symptom network and influencing factors of patients with type 2 diabetes mellitus[J]. Chin J Mod Nurs, 2025, 31(15):2046-2052.
[15]	Jones PJ, Ma RF, McNally RJ. Bridge centrality:a network approach to understanding comorbidity[J]. Multivariate Behav Res, 2021, 56(2):353-367.
[16]	Kusnanto K, Arifin H, Pradipta RO, et al. Resilience-based is-lamic program as a promising intervention on diabetes fati-gue and health-related quality of life[J]. PLoS One, 2022, 17(9):e0273675.
[17]	中华医学会心身医学分会心身内分泌协作学组, 中华预防医学会糖尿病预防与控制专业委员会. 糖尿病共患抑郁诊疗中国专家共识[J]. 中国全科医学, 2026, 29(3):273-292.
	Psychosomatic Endocrinology Collaboration Group of Psycho-somatic Medicine Branch of Chinese Medical Association, Diabetes Prevention and Control Committee of Chinese Pre-ventive Medicine Association. Chinese expert consensus on the diagnosis and treatment of diabetes comorbid with de-pression[J]. Chin Gen Pract, 2026, 29(3):273-292.
[18]	中国微循环学会糖尿病与微循环专业委员会, 中华医学会内分泌学分会基层内分泌代谢病学组. 基层糖尿病微血管疾病筛查与防治专家共识(2024)[J]. 中国全科医学, 2024, 27(32):3969-3986.
	Diabetes and Microcirculation Professional Committee of Chinese Society of Microcirculation; Primary Endocrine and Metabolic Diseases Group of the Chinese Society of Endoc-rinology. Expert consensus on screening and prevention of diabetic microvascular disease for primary care(2024)[J]. Chin Gen Pract, 2024, 27(32):3969-3986.
[19]	Williams R, Karuranga S, Malanda B, et al. Global and regio-nal estimates and projections of diabetes-related health expen-diture:results from the International Diabetes Federation Dia-betes Atlas,9th edition[J]. Diabetes Res Clin Pract, 2020, 162:108072.
[20]	Tang SS, An XD, Sun WJ, et al. Parallelism and non-paralle-lism in diabetic nephropathy and diabetic retinopathy[J]. Front Endocrinol, 2024, 15:1336123.
[21]	Duan DF, Liu M, Ma DY, et al. Exploring symptom clusters in chinese patients with ciabetic kidney disease:a network ana-lysis[J]. Int J Gen Med, 2024, 17:871-884.
[22]	Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale:an instrument for the evaluation of symptom prevalence,characteristics and distress[J]. Eur J Cancer, 1994, 30A(9):1326-1336.
[23]	Cheng KKF, Wong EMC, Ling WM, et al. Measuring the sym-ptom experience of Chinese cancer patients:a validation of the Chinese version of the Memorial Symptom Assessment Scale[J]. J Pain Symptom Manage, 2009, 37(1):44-57.
[24]	Bruera E, Kuehn N, Miller MJ, et al. The Edmonton Symptom Assessment System(ESAS):a simple method for the assess-ment of palliative care patients[J]. J Palliat Care, 1991, 7(2):6-9.
[25]	Dong YX, Chen H, Zheng YY, et al. Psychometric validation of the Edmonton Symptom Assessment System in Chinese patients[J]. J Pain Symptom Manage, 2015, 50(5):712-717.
[26]	Suarez GA, Opfer-Gehrking TL, Offord KP, et al. The Autono-mic Symptom Profile:a new instrument to assess autonomic symptoms[J]. Neurology, 1999, 52(3):523-528.
[27]	Greco C, Di Gennaro F, D’Amato C, et al. Validation of the Composite Autonomic Symptom Score 31(COMPASS 31) for the assessment of symptoms of autonomic neuropathy in people with diabetes[J]. Diabet Med, 2017, 34(6):834-838.
[28]	Zhang ZY, Ma YJ, Fu LJ, et al. Combination of Composite Autonomic Symptom Score 31 and heart rate variability for dia-gnosis of cardiovascular autonomic neuropathy in people with type 2 diabetes[J]. J Diabetes Res, 2020, 2020(1):5316769.
[29]	Feldman EL, Stevens MJ, Thomas PK, et al. A practical twostep quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy[J]. Diabetes Care, 1994, 17(11):1281-1289.
[30]	张红梅, 刘义珍, 卢金玉. 密歇根神经筛查量表对糖尿病神经病变筛查的适用性评价[J]. 中国卫生统计, 2021, 38(2):247-249.
	Zhang HM, Liu YZ, Lu JY. Applicability evaluation of Michi-gan Neuroscreening Scale for diabetic neuropathy screening[J]. Chin J Health Stat, 2021, 38(2):247-249.
[31]	Arbuckle RA, Humphrey L, Vardeva K, et al. Psychometric eva-luation of the Diabetes Symptom Checklist-Revised(DSC-R):a measure of symptom distress[J]. Value Health, 2009, 12(8):1168-1175.
[32]	罗倩. 2型糖尿病患者症状负担评估量表的汉化修订及应用研究[D]. 南昌: 南昌大学, 2023.
	Luo Q. Chinese revision and application study of Symptom Burden Assessment Scale for patients with type 2 diabetes mellitus[D]. Nanchang: Nanchang University, 2023.
[33]	Herder C, Zhu AN, Schmitt A, et al. Biomarkers of inflamma-tion and improvement in depressive symptoms in type 1 and type 2 diabetes:differential associations with depressive sym-ptom clusters[J]. Diabetologia, 2025, 68(9):2057-2068.
[34]	Deng RJ, Zhu SH, Fan B, et al. Exploring the correlations bet-ween six serological inflammatory markers and different stages of type 2 diabetic retinopathy[J]. Sci Rep, 2025, 15(1):1567.
[35]	Xhardo K, Xhardo E, Bratu M, et al. The impact of biodex balance on improving coordination and static balance in patients with diabetic peripheral neuropathy[J]. Life(Basel), 2025, 15(7):1030.
[36]	胡哲, 雷丹丹, 赵益, 等. 基于健康行为改变整合理论的护理干预对糖尿病视网膜病变患者的影响[J]. 中华护理杂志, 2024, 59(3):300-307.
	Hu Z, Lei DD, Zhao Y, et al. The effect of nursing inter-vention based on the integrated theory of health behavior change on the health behavior of patients with diabetes retinopathy[J]. Chin J Nurs, 2024, 59(3):300-307.
[37]	Abbas Q, Latif S, Ayaz Habib H, et al. Cognitive behavior the-rapy for diabetes distress,depression,health anxiety,quality of life and treatment adherence among patients with type-Ⅱ diabetes mellitus:a randomized control trial[J]. BMC Psychiatry, 2023, 23(1):86.
[38]	Nahum-Shani I, Smith SN, Spring BJ, et al. Just-in-time adap-tive interventions(JITAIs) in mobile health:key components and design principles for ongoing health behavior support[J]. Ann Behav Med, 2018, 52(6):446-462.
[39]	王晴, 黄晓婷, 唐四元, 等. 即时适配干预在护理领域中的应用进展[J]. 中华护理杂志, 2024, 59(4):490-495.
	Wang Q, Huang XT, Tang SY, et al. The application progress of just-in-time adaptive intervention in nursing[J]. Chin J Nurs, 2024, 59(4):490-495.
[40]	Wang LY, Miller L. Assessment and disruption of ruminative episodes to enhance mobile cognitive behavioral therapy just-in-time adaptive interventions in clinical depression:pilot ran-domized controlled trial[J]. JMIR Form Res, 2023, 7:e37270.
[41]	Hermanns N, Ehrmann D, Kulzer B, et al. Somatic and mental symptoms associated with dysglycaemia,diabetes-related com-plications and mental conditions in people with diabetes:assessments in daily life using continuous glucose monitoring and ecological momentary assessment[J]. Diabetes Obes Metab, 2025, 27(1):61-70.